Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where EXPI advanced for three days, in of 302 cases, the price rose further within the following month. The odds of a continued upward trend are .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where EXPI's RSI Oscillator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for EXPI just turned positive on February 14, 2025. Looking at past instances where EXPI's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
EXPI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 51 cases where EXPI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on February 21, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on EXPI as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The 50-day moving average for EXPI moved below the 200-day moving average on January 30, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EXPI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for EXPI entered a downward trend on January 24, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.333) is normal, around the industry mean (3.493). EXPI has a moderately high P/E Ratio (369.000) as compared to the industry average of (60.036). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.782). Dividend Yield (0.019) settles around the average of (0.055) among similar stocks. P/S Ratio (0.362) is also within normal values, averaging (9.916).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. EXPI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EXPI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
a development stage company
Industry RealEstateDevelopment
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PEAPX | 27.54 | 0.06 | +0.22% |
Principal Glb Emerging Markets R3 | |||
HMECX | 18.91 | -0.01 | -0.05% |
NexPoint Merger Arbitrage C | |||
MINFX | 34.05 | -0.17 | -0.50% |
MFS International Intrinsic Value R2 | |||
TQMVX | 17.90 | -0.22 | -1.21% |
T. Rowe Price Integrated US LCV Eq | |||
SPFIX | 75.64 | -1.31 | -1.70% |
Shelton S&P 500 Index Investor |
A.I.dvisor indicates that over the last year, EXPI has been loosely correlated with RDFN. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if EXPI jumps, then RDFN could also see price increases.
Ticker / NAME | Correlation To EXPI | 1D Price Change % | ||
---|---|---|---|---|
EXPI | 100% | -9.52% | ||
RDFN - EXPI | 61% Loosely correlated | -9.66% | ||
COMP - EXPI | 58% Loosely correlated | -8.18% | ||
RMAX - EXPI | 58% Loosely correlated | -10.25% | ||
OPEN - EXPI | 53% Loosely correlated | -6.08% | ||
HOUS - EXPI | 52% Loosely correlated | -3.37% | ||
More |